CEQUA’s nanomicellar (NCELL) technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Urges them to focus on tele-consultation like eSanjeevani and efficient monitoring of those in home isolation
New role strengthens Quantori’s global leadership position in data science & digital IT
The covid health center will be managed and administered by the district administration of Ballari
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening
Phase 1/2 trial of E-602 expected to open in Q1 2022 in patients with solid tumours
Oral semaglutide is a co-formulation of GLP-1RA semaglutide with an absorption enhancer SNAC which protects semaglutide from undergoing degradation in the stomach
This is the company’s first partnership arrangement in China
Subscribe To Our Newsletter & Stay Updated
